Medicamen Organics Limited was incorporated in 1995 and develops, manufactures, and distributes pharmaceutical dosages including generic dosages in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders for the Government (including State Governments and Central Governments) and private entities as a contract manufacturer/third party manufacturer.

The company’s product list comprises 84 products and offers a wide range of drugs such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, proton pump inhibitors, antihistamines, antihypertensive drugs, lipid preparations, antiparasitics, multivitamin preparations, multimineral and non-steroidal anti-inflammatory drugs (NSAIDS).

The company’s products are marketed throughout India as well as in African, CIS, and South East Asian countries such as Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya through third-party distributors.

The company has two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, covering an area of 21,536 Sq. Ft. As on September 30, 2023, the company has entered into contract manufacturing with 38 domestic partners and 12 merchant exporters.

For year/ period ended ( Rs. in lacs.)

For year/ period ended ( in Cr.)

• Experienced Promoters and Management Team;
• Long standing relationships with customers;
• Efficient operational team;
• Consistent financial performance;

• Funding of expenses proposed to be incurred towards Product registration in the international markets;
• Plant updation and increase in production capacity;
• Funding working capital requirements of our Company; and
• General Corporate Purposes.

The company is operating in a highly competitive and fragmented segment of Pharma products. It posted average financial performance for the reported periods with boosted bottom line for FY24. Well-informed investors may park moderate funds for the long term rewards.